Draxis Health’s Q3 revenues climb 10%

Radiopharmaceutical firm Draxis Health reported third-quarter revenues from continuing operations of $8.9 million, up 10% compared with the $8.1 million posted in the same period last year. For the quarter (end-September 30), the Mississauga, Ontario-based firm had net income of $392,000, compared with net income of $259,000 in the third quarter of 2001. Draxis Health attributed the quarterly gains to increased product sales, particularly in its radiopharmaceutical business, and to higher royalty and licensing revenues.

By AuntMinnie.com staff writers
November 14, 2002

Related Reading

Draxis Health turns in record Q1, May 16, 2002

DraxImage brings production in-house, March 14, 2002

Draxis gets NRC approval for BrachySeed Pd-103, November 13, 2001

Draxis revenues climb, November 8, 2001

DraxImage to make radiotherapy capsules for Bracco, August 23, 2001

Copyright © 2002 AuntMinnie.com

Page 1 of 435
Next Page